Schain Research
Malin Almgren is a seasoned professional with extensive experience in the healthcare and research sectors. Currently, Almgren serves as a Board Member for CombiGene, Redsense Medical, and Experia Nordic Oy, alongside a role as Advisory Board Member at Experia Corporate Finance Advisors. As Chief Executive Officer at Schain Research, Almgren leads efforts in health data sciences and real-world evidence to enhance drug development and patient outcomes. Previous roles include Board Member at DP Services AB, conducting clinical research at Karolinska Institutet, and leading strategic partnerships at Tundra Research Network and Tundra Fonder AB. Almgren holds a PhD in Medicine from Karolinska Institutet and an MSc in Chemistry from Stockholm University.
This person is not in any teams
Schain Research
Schain Research is a research consultancy company specialized in health data sciences and real world evidence to support pharmaceutical companies throughout all phases of drug development. We advance knowledge and contribute to accelerated drug development processes, evidence based healthcare and improved patient outcomes by applying advanced analytics on population-based data sources. Our team has extensive experience from R&D, medical affairs, market access, biostatistics, epidemiology and economics.